148 related articles for article (PubMed ID: 30208353)
1. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
[TBL] [Abstract][Full Text] [Related]
2. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
[TBL] [Abstract][Full Text] [Related]
3. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
[TBL] [Abstract][Full Text] [Related]
4. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
[TBL] [Abstract][Full Text] [Related]
5. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH
Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318
[TBL] [Abstract][Full Text] [Related]
6. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Park JH; Katagiri T; Chung S; Kijima K; Nakamura Y
Neoplasia; 2011 Apr; 13(4):320-6. PubMed ID: 21472136
[TBL] [Abstract][Full Text] [Related]
7. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
Gao F; Zheng G
Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886
[TBL] [Abstract][Full Text] [Related]
8. GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.
Mao Y; Zhang Y; Fan S; Chen L; Tang L; Chen X; Lyu J
Int J Biol Sci; 2019; 15(1):169-182. PubMed ID: 30662357
[TBL] [Abstract][Full Text] [Related]
9. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
Kimura R; Yoshimaru T; Matsushita Y; Matsuo T; Ono M; Park JH; Sasa M; Miyoshi Y; Nakamura Y; Katagiri T
Int J Oncol; 2020 Feb; 56(2):581-595. PubMed ID: 31894262
[TBL] [Abstract][Full Text] [Related]
10. GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.
Niang B; Jin L; Chen X; Guo X; Zhang H; Wu Q; Padhiar AA; Xiao M; Fang D; Zhang J
Mol Cell Biochem; 2016 Jan; 411(1-2):393-402. PubMed ID: 26541755
[TBL] [Abstract][Full Text] [Related]
11.
Lavrsen K; Dabelsteen S; Vakhrushev SY; Levann AMR; Haue AD; Dylander A; Mandel U; Hansen L; Frödin M; Bennett EP; Wandall HH
J Biol Chem; 2018 Jan; 293(4):1298-1314. PubMed ID: 29187600
[TBL] [Abstract][Full Text] [Related]
12. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
[TBL] [Abstract][Full Text] [Related]
13. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels.
Huang T; Wu Q; Huang H; Zhang C; Wang L; Wang L; Liu Y; Li W; Zhang J; Liu Y
Biochim Biophys Acta Gen Subj; 2022 Jan; 1866(1):130046. PubMed ID: 34743989
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
[TBL] [Abstract][Full Text] [Related]
15. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.
Lin TC; Chen ST; Huang MC; Huang J; Hsu CL; Juan HF; Lin HH; Chen CH
Oncotarget; 2017 Jun; 8(26):42588-42601. PubMed ID: 28388560
[TBL] [Abstract][Full Text] [Related]
16. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78.
Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q
Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740
[TBL] [Abstract][Full Text] [Related]
17. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
18. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
19. Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
Ito T; Kamijo S; Izumi H; Kohno K; Amano J; Ito K
Breast Cancer Res Treat; 2012 May; 133(1):145-59. PubMed ID: 21863258
[TBL] [Abstract][Full Text] [Related]
20. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]